AU2005254863A1 - Compound for preparing thiazole by aminomethylation - Google Patents

Compound for preparing thiazole by aminomethylation Download PDF

Info

Publication number
AU2005254863A1
AU2005254863A1 AU2005254863A AU2005254863A AU2005254863A1 AU 2005254863 A1 AU2005254863 A1 AU 2005254863A1 AU 2005254863 A AU2005254863 A AU 2005254863A AU 2005254863 A AU2005254863 A AU 2005254863A AU 2005254863 A1 AU2005254863 A1 AU 2005254863A1
Authority
AU
Australia
Prior art keywords
compound
parts
thiazole
formula
hexahydrotriazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2005254863A
Other versions
AU2005254863B2 (en
Inventor
Shinzo Seko
Naoyuki Takano
Kazuyuki Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of AU2005254863A1 publication Critical patent/AU2005254863A1/en
Application granted granted Critical
Publication of AU2005254863B2 publication Critical patent/AU2005254863B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

WO 2005/123704 PCT/JP2005/011095 DESCRIPTION PROCESS FOR PREPARING THIAZOLE BY AMINOMETHYLATION 5 Technical Field The present invention relates to a process for preparing a thiazole compound. Background Art 10 A thiazole compound, typically, 2-chloro-5 (aminomethyl)thiazole, of formula (3):
NH
2 (3) wherein X represents a hydrogen atom or a halogen atom, is a useful compound as an intermediate for pharmaceuticals 15 and agrochemicals (see, e.g., JP 7-14916 B). For preparing the thiazole compound, several processes have been known. For example, (a) a compound of formula (1): / X2 wherein X 1 is as defined above, and X 2 represents a halogen 20 atom, is reacted with hexamethylenetetramine, followed by hydrolysis (see, e.g., JP 4-234864 A and JP 4-21674 A); (b) the compound of formula (1) is reacted with potassium phthalimide, followed by hydrazinolysis (see, e.g., JP 4- WO 2005/123704 PCT/JP2005/011095 2 234864 A); (c) the compound of formula (1) is reacted with formamide, followed by hydrolysis (see, e.g., JP 5-286936 A); and (d) the compound of formula (1) is reacted with ammonia (see, e.g., JP 4-234864 A and JP 2000-143648 A). 5 However, the above processes (a) to (c) are not necessarily satisfactory from an industrial point of view because yields of the target thiazole compound of formula (3) are low in these processes. Although the above process (d) has an advantage over the processes (a) to (c) because 10 of the use of low-priced ammonia, a considerable amount of a by-product compound of formula (4): xi S X Il H j(4) wherein X 1 is as defined above, is formed even when using ammonia in 20 mol-fold amount or more relative to the 15 compound of formula (1), which results in a low yield of the target thiazole compound of formula (3). Therefore, further improvement has been desired. Disclosure of Invention 20 Under these circumstances, the present inventors have studied intensively to develop an industrially advantageous process for preparing the thiazole compound of formula (3) using low-priced ammonia with suppressing the formation of the by-product, i.e., the compound of formula (4), and have WO 2005/123704 PCT/JP2005/011095 3 found that the target thiazole compound of formula (3) can be prepared with suppressing the formation of the by product, the compound of formula (4), by reacting the compound of formula (1) with ammonia and formaldehyde, 5 which is also low-priced and readily available, to obtain a hexahydrotriazine compound, which is a novel compound, of formula (2): xi S N N (2) x1 N N S wherein X1 is as defined above, and then hydrolyzing the 10 hexahydrotriazine compound of formula (2). Thus, the present invention have been completed. That is, the present invention provides a process for preparing a thiazole compound of formula (3):
NH
2 15 wherein X1 is as defined above, which comprises the steps of: reacting a compound of formula (1): 1S) x1- \ / X (1) WO 2005/123704 PCT/JP2005/011095 4 wherein X 1 represents a hydrogen atom, or a halogen atom, and X2 represents a halogen atom, with ammonia and formaldehyde to obtain a hexahydrotriazine compound of formula (2): xi SN N N (2) 5 N wherein X1 is as defined above, and hydrolyzing the resulting hexahydrotriazine compound of formula (2). Best Mode for Carrying Out the Invention 10 First, the step for reacting a compound of formula (1): x S 2W x2 wherein X 1 represents a hydrogen atom or a halogen atom, and X2 represents a halogen atom (hereinafter, abbreviated 15 as compound (1)), with ammonia and formaldehyde to obtain a hexahydrotriazine compound of formula (2): WO 2005/123704 PCT/JP2005/011095 5 X1 S N N N (2) x N N X wherein X1 is as defined above (hereinafter, abbreviated as hexahydrotriazine compound (2)), will be explained. In compound (1), XI represents a hydrogen atom or a 5 halogen atom, and X2 represents a halogen atom. Examples of the halogen atom include a chlorine atom, a bromine atom, an iodine atom, and the like. Examples of compound (1) include, for example, 5 (chloromethyl)thiazole, 2-chloro-5-(chloromethyl)thiazole, 10 2-chloro-5-(bromomethyl)thiazole, 2-bromo-5 (bromomethyl)thiazole, 2-chloro-5-(iodomethyl)thiazole, 2 bromo-5-(iodomethyl)thiazole, 2-iodo-5- (iodomethyl)thiazole, and the like. Compound (1) can be prepared according to a known 15 method, for example, the method described in JP 4-234864 A. Compound (1) may be in the free form, or may be in an acid addition salt form. Examples of the acid of acid addition salt include inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, perchloric acid, and 20 the like; and organic acids such as acetic acid, WO 2005/123704 PCT/JP2005/011095 6 methanesulfonic acid, trifluoromethanesulfonic acid, p toluenesulfonic acid, and the like. As ammonia, ammonia gas may be used, or liquid ammonia may be used. Further, ammonia water may be used, or a 5 solution of ammonia in an organic solvent that can solubilize ammonia such as methanol may be used. From a viewpoint of ease of handling and yield, a solution of ammonia in an organic solvent is preferably used. Ammonia is usually used in the amount of 1 to 30 moles, 10 preferably 2 to 15 moles, and more preferably 2 to 10 moles per mol of compound (1). In case of using compound (1) in the form of an acid addition salt, the amount of ammonia that may be used can be determined by taking the acid in acid addition salt into consideration. 15 As formaldehyde, formaldehyde gas may be used, but from a viewpoint of handling, paraformaldehyde or formalin is preferably used, and paraformaldehyde is more preferably used. Formaldehyde is usually used in the amount of 1 to 10 moles, preferably 1 to 8 moles, and more preferably 1 to 20 5 moles per mol of compound (1). Further, preferably, the amount of formaldehyde that may be used per mol of compound (1) is smaller than that of ammonia. The reaction temperature is usually 15 to 100*C, preferably 20 to 900C. The reaction is usually carried out 25 at atmospheric pressure or under pressure of not higher WO 2005/123704 PCT/JP2005/011095 7 than 0.5 MPa (gauge pressure). The reaction may be carried out with no solvent, but preferably carried out in an inert solvent. Examples of the solvent include, for example, alcohols such as methanol, 5 ethanol, n-propanol, isopropanol, and the like; aromatic hydrocarbons such as toluene, xylene, and the like; halogenated hydrocarbons such as chlorobenzene, dichlorobenzene, and the like; aliphatic hydrocarbons such as hexane, heptane, cyclohexane, and the like; ethers such 10 as diethyl ether, tetrahydrofuran, dioxane, and the like; aprotic polar solvents such as acetonitrile, propionitrile, dimethylsulfoxide, N,N-dimethyl acetamide, and the like; and water. They can be used alone or as a mixture of the solvents. Alcohols and water are preferable, and alcohols 15 are more preferable. The amount of the solvent that may be used is usually 1 to 10 parts by weight per part by weight of compound (1). The reaction is usually carried out by mixing and bringing compound (1) into contact' with ammonia and 20 formaldehyde, and the order of mixing thereof is not specifically limited. For example, compound (1) may be mixed with ammonia and formaldehyde to carry out the reaction at a given temperature, or compound (1) mixed in advance with formaldehyde may be added to ammonia to carry 25 out the reaction. Alternatively, ammonia and formaldehyde WO 2005/123704 PCT/JP2005/011095 8 may be mixed and to this mixture is added compound (1) to carry out the reaction. Further, to formaldehyde may be added compound (1) and ammonia simultaneously to carry out the reaction. Furthermore, to ammonia may be added 5 compound (1) and formaldehyde simultaneously to carry out the reaction. If necessary, the reaction may be carried out in the presence of a quaternary ammonium salt such as triethylbenzylammonium chloride, tri-n-octylmethylammonium 10 chloride, trimethyldecylammonium chloride, tetramethylammonium bromide, tetra-n-butylammonium bromide, or the like; or a phase transfer catalyst such as crown ether, or the like. It is considered that, by this reaction, a 15 methyleneimine compound which is an unstable intermediate, and of formula (5): \ / N=CH2 (5) wherein X 1 is as defined above, is formed, followed by trimerization thereof to form hexahydrotriazine compound 20 (2). After completion of the reaction, a reaction mixture containing hexahydrotriazine compound (2) is obtained, and hexahydrotriazine compound (2) can be isolated by, for example, concentrating the reaction mixture. Alternatively, WO 2005/123704 PCT/JP2005/011095 9 hexahydrotriazine compound (2) can be isolated as crystals by cooling the reaction mixture as it is or after partial concentration. Further, hexahydrotriazine compound (2) can be isolated by adding water and a hydrophobic organic 5 solvent to the reaction mixture as it is or after concentration thereof to subject the mixture to extraction treatment, and concentrating the resulting organic layer. Furthermore, hexahydrotriazine compound (2) can be isolated as an acid addition salt such as its hydrochloride, sulfate, 10 or the like. Examples of the hydrophobic organic solvent include halogenated hydrocarbons such as chlorobenzene, dichlorobenzene, and the like; esters such as ethyl acetate, butyl acetate, and the like; ketones such as methyl ethyl 15 ketone, methyl isobutyl ketone, and the like; and aromatic hydrocarbons such as toluene, xylene, and the like. They can be used-alone or as a mixture of the solvents. The amount thereof that may be used is not specifically limited. Alternatively, without isolating hexahydrotriazine 20 compound (2) from the reaction mixture, the reaction mixture or an organic layer containing hexahydrotriazine compound (2) may be used in the subsequent hydrolyzing step described hereinafter. Examples of h6xahydrotriazine compound (2) thus 25 obtained include, for example, 1,3,5-tris{(thiazol-5- WO 2005/123704 PCT/JP2005/011095 10 yl)methyl}-1,3,5-hexahydrotriazine, 1,3,5-tris{ (2 chlorothiazol-5-yl)methyll-1,3,5-hexahydrotriazine, 1,3,5 tris{(2-bromothiazol-5-yl)methyl}-1,3,5-hexahydrotriazine, and the like. 5 Next, the step for preparing the thiazole compound of formula (3):
NH
2 (3) wherein X1 is as defined above (hereinafter, abbreviated as thiazole compound (3)), by hydrolyzing hexahydrotriazine 10 compound (2) obtained will be explained. This step is hydrolysis of hexahydrotriazine compound (2) obtained in the previous step to convert it into thiazole compound (3), and usually carried out by mixing hexahydrotriazine compound (2) and an aqueous solution of 15 an acid to allow to come into contact with each other. Examples of the aqueous solution of an acid include, for example, an aqueous solution of hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid, or the like. An aqueous solution of hydrochloric acid or sulfuric acid is 20 preferable. The concentration of the acid in the aqueous solution is not specifically limited. The acid is usually used in the amount of 1 to 30 moles, preferably 3 to 15 moles per mol of hexahydrotriazine compound (2). As described above, hexahydrotriazine compound (2) WO 2005/123704 PCT/JP2005/011095 11 formed in the previous step may be isolated from the reaction mixture, and then hydrolyzed, or the reaction mixture or an organic layer containing hexahydrotriazine compound (2) may be subjected directly to the hydrolysis 5 without isolating hexahydrotriazine compound (2). The temperature for hydrolysis is usually 10 to 100'C, preferably 25 to 70*C. As hydrolysis of hexahydrotriazine compound (2) proceeds, formaldehyde is formed as a by-product. In order 10 to facilitate removal of the by-product, formaldehyde, the hydrolysis of hexahydrotriazine compound (2) is preferably carried out in the presence of a lower alcohol compound to convert formaldehyde formed as the by-product into acetal. Examples of the lower alcohol compound include, for example, 15 lower alcohol compounds having 1 to 4 carbon atoms such as methanol, ethanol, and the like. The lower alcohol compound is usually used in the amount of not less than 1.5 moles, preferably not less than 2 moles, more preferably not less than 2.5 moles per mol of hexahydrotriazine 20 compound (2), and the upper limit is not specifically limited. When the reaction mixture containing hexahydrotriazine compound (2) is used as it is, and when the lower alcohol compound is present in the reaction mixture, the amount of the lower alcohol compound that may 25 be used may be determined by taking the amount thereof in WO 2005/123704 PCT/JP2005/011095 12 the reaction mixture into consideration. Further, sometimes, formaldehyde remains in the reaction mixture. In such a case, the lower alcohol compound may be used in an amount sufficient to convert not only formaldehyde 5 formed as the by-product but also formaldehyde remained in the reaction mixture into acetal. Of course, after the hydrolysis of hexahydrotriazine compound (2), formaldehyde may be converted into acetal. After completion of the hydrolysis, thiazole compound 10 (3) or an acid addition salt thereof can be isolated by, for example, concentration. Alternatively, thiazole compound (3) can be isolated by concentrating the reaction mixture, adding an aqueous solution of an alkali and a hydrophobic organic solvent thereto to subject the mixture 15 to extraction treatment, and concentrating the resulting organic layer. Examples of the aqueous solution of an alkali include an aqueous solution of an alkali metal hydroxide such as an aqueous sodium hydroxide solution, or the like. The amount of the aqueous solution of an alkali 20 that may be used is such that pH of the aqueous layer upon extraction is within the range of usually 8 to 14, preferably 10 to 14. Further, an acid addition salt of thiazole compound (3) can be isolated by mixing the organic layer obtained in 25 the above extraction with an aqueous solution of an acid, WO 2005/123704 PCT/JP2005/011095 13 separating into layers to obtain an aqueous solution containing an acid addition salt of thiazole compound (3) and, optionally, partially concentrating the aqueous solution. Further, crystals of an acid addition salt of 5 thiazole compound (3) can be precipitate by adding an insufficient solvent scarcely dissolving the acid addition salt of thiazole compound (3) to the above aqueous solution. Examples of the aqueous solution of an acid include an aqueous solution of an acid such as hydrochloric acid, 10 sulfuric acid, acetic acid, methanesulfonic acid, or the like. The amount of the aqueous solution that may be used is such that pH of the aqueous layer upon extraction is within the range of usually 2.5 to 5.5, preferably 3 to 5. If the aqueous solution containing the acid addition salt 15 of thiazole compound (3) thus obtained is colored, the solution may be subjected to decolorization treatment by, for example, adding a decoloring agent such as activated charcoal to the aqueous solution. Examples of thiazole compound (3) thus obtained 20 include 5-(aminomethyl)thiazole, 2-chloro-5 (aminomethyl)thiazole, 2-bromo-5-(aminomethyl)thiazole, and the like. The present invention will be further illustrated in detail by the following Examples but the present invention 25 is not limited to these Examples. For the analyses in WO 2005/123704 PCT/JP2005/011095 14 Examples, high performance liquid chromatography (HPLC) was used; and a yield and a recovery were calculated on the basis of 2-chloro-5-(chloromethyl)thiazole. In the following Examples, all the parts and percents are by 5 weight unless otherwise stated. Example 1 To a glass autoclave, 95.3 parts of 2-chloro-5 (chloromethyl)thiazole (content: 96.5%), 51.9 parts of paraformaldehyde (content: 95%) and 311 parts of a 12% 10 ammonia solution in methanol were charged, and the mixture was reacted with stirring at an inner temperature of 70'C for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.09 MPa. The reaction mixture containing 1,3,5-tris{(2-chlorothiazol-5-yl)methyl}-1,3,5 15 hexahydrotriazine thus obtained was transferred into a four-neck flask by washing the autoclave with 150 parts of methanol, bubbled with nitrogen for 15 minutes to expel ammonium remaining in the reaction mixture, and then concentrated under reduced pressure to distill off 60 parts 20 of methanol. To the resultant concentrated residue were added 60 parts of methanol and 188 parts of 35% hydrochloric acid, and the mixture was refluxed at an inner temperature of 60*C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 40'C, and then 25 concentrated under reduced pressure to obtain 246 parts of WO 2005/123704 PCT/JP2005/011095 15 a concentrated residue. To the concentrated residue were added 57.5 parts of water, 282 parts of methyl isobutyl ketone and 367 parts of an aqueous 27% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture 5 to extraction treatment, and obtaining an organic layer and an aqueous layer. The aqueous layer was further extracted three times with methyl isobutyl ketone, and the methyl isobutyl ketone layers obtained were combined with the previously obtained organic layer to obtain a solution 10 containing 2-chloro-5-(aminomethyl)thiazole. The yield of 2-chloro-5-(aminomethyl)thiazole was 91.2%, and the yield of bis{ (2-chlorothiazol-5-yl)methyl}amine was 2.8%. The solution containing 2-chloro-5 (aminomethyl)thiazole thus obtained was washed with 33.6 15 parts of an aqueous 14% sodium hydroxide solution, followed by addition of 100 parts of water and 55.7 parts of 35% hydrochloric acid to adjust to pH 3.3. Then, the layers were separated, and 230 parts of the resultant aqueous layer was concentrated under reduced pressure to obtain 194 20 parts of a concentrated residue. To the concentrated residue was added 1 part of activated charcoal and the mixture was maintained with stirring at room temperature for 1 hour. The activated charcoal was filtered and washed with about 10 parts of water to obtain 204 parts of an 25 aqueous solution containing 2-chloro-5- WO 2005/123704 PCT/JP2005/011095 16 (aminomethyl)thiazole hydrochloride. The content of 2 chloro-5-(aminomethyl)thiazole hydrochloride was 42.4% and the yield was 85.2%. Example 2 5 To a glass autoclave, 16.7 parts of 2-chloro-5 (chloromethyl)thiazole (content: 95.7%), 9.04 parts of paraformaldehyde (content: 95%) and 16.7 parts of methanol were charged, and adjusted to an inner temperature of 700C. To this was added dropwise 57.9 parts by weight of a 14% 10 ammonia solution in methanol over 1 hour. After completion of addition, the mixture was reacted at the same temperature for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.15 MPa. The reaction mixture containing 1,3,5-tris{ (2-chlorothiazol-5 15 yl)methyl}-1,3,5-hexahydrotriazine obtained was transferred into a four-neck flask by washing the autoclave with 50 parts of methanol, and concentrated under reduced pressure to obtain 42.7 parts of a concentrated residue. To the concentrated residue was added 73.2 parts of methanol and 20 32.8 parts of 35% hydrochloric acid, and the mixture was refluxed at an inner temperature of 60'C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 400C, and then concentrated under reduced pressure to obtain 42.2 parts of a concentrated residue. 25 To the concentrated residue were added 49 parts of methyl WO 2005/123704 PCT/JP2005/011095 17 isobutyl ketone and 69 parts of an aqueous 27% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture to extraction treatment, and obtaining an organic layer and an aqueous layer. The aqueous layer was 5 further extracted three times with methyl isobutyl ketone, and the methyl isobutyl ketone layers obtained were combined with the previously obtained organic layer to obtain a solution containing 2-chloro-5 (aminomethyl)thiazole. The yield of 2-chloro-5 10 (aminomethyl)thiazole was 87.1%, and the yield of bis{(2 chlorothiazol-5-yl)methyl}amine was 1.2%. Example 3 To a glass autoclave, 16.8 parts of 2-chloro-5 (chloromethyl)thiazole (content: 95.6%), 9.05 parts of 15 paraformaldehyde (content: 95%) and 135 parts of a 24% ammonia solution in methanol were charged, and the mixture was reacted with stirring at an inner temperature of 70'C for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.37 MPa. The reaction mixture 20 containing 1,3,5-tris{ (2-chlorothiazol-5-yl)methyl}-1,3,5 hexahydrotriazine obtained was transferred into a four-neck flask by washing the autoclave with 20 parts of methanol, and concentrated under reduced pressure to obtain 40 parts by a concentrated residue. To the concentrated residue 25 were added 73.2 parts of methanol and 32.8 parts of 35% WO 2005/123704 PCT/JP2005/011095 18 hydrochloric acid, and refluxed at an inner temperature of about 60*C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 40'C, and then concentrated under reduced pressure to obtain 41.7 parts of 5 a concentrated residue. To the concentrated residue were added 49 parts of toluene and 51.8 parts of an aqueous 30% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture to extraction treatment and obtaining an organic layer and an aqueous layer. The 10 aqueous layer was further extracted three times with toluene, and the toluene layers obtained were combined with the previously obtained organic layer to obtain a solution containing 2-chloro-5-(aminomethyl)thiazole. The yield of 2-chloro-5-(aminomethyl)thiazole was 93.3%, and the yield 15 of bis{.(2-chlorothiazol-5-yl)methyl}amine was 2.6%. The solution containing 2-chloro-5 (aminomethyl)thiazole obtained was washed with 5.8 parts of an aqueous 14% sodium hydroxide solution, followed by addition of 17.5 parts of water and 9 parts of 35% 20 hydrochloric acid to adjust to pH 4.9 to obtain 38.9 parts of an aqueous solution containing 2-chloro-5 (aminomethyl)thiazole hydrochloride. The content of 2 chloro-5-(aminomethyl)thiazole hydrochloride was 38.6% and the yield was 85.1%. 25 Example 4 WO 2005/123704 PCT/JP2005/011095 19 To a glass autoclave, 16.6 parts of 2-chloro-5 (chloromethyl)thiazole (content: 96.5%), 9.04 parts of paraformaldehyde (content: 95%) and 54.1 parts of a 10.5% ammonia solution in methanol were charged, and the mixture 5 was reacted with stirring at an inner temperature of 700C for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.08 MPa. The reaction mixture containing 1,3,5-tris{ (2-chlorothiazol-5-yl)methyl}-1,3,5 hexahydrotriazine obtained was transferred into a four-neck 10 flask by washing the autoclave with 60 parts of methanol, and then concentrated under reduced pressure to obtain 40 parts of a concentrated residue. To the concentrated residue were added 73.2 parts of methanol and 32.8 parts of 35% hydrochloric acid, and the mixture was refluxed at an 15 inner temperature of 600C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 40*C, and then concentrated under reduced pressure to obtain 42.8 parts of a concentrated residue. To the concentrated residue were added 11.4 parts of water, 49 parts of methyl 20 isobutyl ketone and 60.9 parts of an aqueous 27% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture to extraction treatment, and obtaining an organic layer and an aqueous layer. The aqueous layer was further extracted three times with methyl isobutyl ketone, 25 and the methyl isobutyl ketone layers obtained were WO 2005/123704 PCTIJP2005/011095 20 combined with the previously obtained organic layer to obtain a solution containing 2-chloro-5 (aminomethyl)thiazole. The yield of 2-chloro-5 (aminomethyl)thiazole was 91.2%, and the yield of bis{(2 5 chlorothiazol-5-yl)methylamine was 2.0%. Example 5 To a glass autoclave, 29 parts of 2-chloro-5 (chloromethyl)thiazole (content: 96.5%), 10.5 parts of paraformaldehyde (content: 95%) and 94.6 parts of a 9% 10 ammonia solution in methanol were charged, and the mixture was reacted with stirring at an inner temperature of 70*C for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.09 MPa. The reaction mixture containing 1,3,5-tris{(2-chlorothiazol-5-yl)methyl}-1,3,5 15 hexahydrotriazine obtained was transferred into four-neck flask by washing the autoclave with 60 parts of methanol, and then concentrated under reduced pressure to obtain 57.8 parts of a concentrated residue. To the concentrated residue were added 128 parts of methanol and 57.4 parts of 20 35% hydrochloric acid, and the mixture was refluxed at an inner temperature of 60 0 C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 400C, and then concentrated under reduced pressure to obtain 75.1 parts of a concentrated residue. To the concentrated 25 residue were added 20 parts of water, 85.7 parts of methyl WO 2005/123704 PCT/JP2005/011095 21 isobutyl ketone and 113.5 parts of an aqueous 27% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture to extraction treatment, and obtaining an organic layer and an aqueous layer. The aqueous layer was 5 further extracted with methyl isobutyl ketone, and the methyl isobutyl ketone layers obtained were combined with the previously obtained organic layer to obtain a solution containing 2-chloro-5-(aminomethyl)thiazole. The yield of 2-chloro-5-(aminomethyl)thiazole was 86.2%, and the yield 10 of bis{(2-chlorothiazol-5-yl)methyl}amine was 4.3%. Example 6 To a glass autoclave, 10.6 parts of 2-chloro-5 (chloromethyl)thiazole (content: 95%), 2.3 parts of paraformaldehyde (content: 95%) and 30.5 parts of a 10% 15 ammonia solution in methanol were charged, and the mixture was reacted with stirring at an inner temperature of 70'C for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.10 MPa. The reaction mixture containing 1,3,5-tris{(2-chlorothiazol-5-yl)methyl}-1,3,5 20 hexahydrotriazine obtained was transferred into a four-neck flask by washing the autoclave with 30 parts of methanol, and then concentrated under reduced pressure to obtain 27.1 parts by weight of a concentrated residue. To the concentrated residue were added 45.8 parts of methanol and 25 11.8 parts of 35% hydrochloric acid, and the mixture was WO 2005/123704 PCT/JP2005/011095 22 refluxed at an inner temperature of 60 0 C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 40'C, and then concentrated under reduced pressure to obtain 35.8 parts of a concentrated residue. 5 To the concentrated residue were added 30.6 parts of methyl isobutyl ketone and 24.5 parts of an aqueous 30% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture to extraction treatment, and obtaining an organic layer and an aqueous layer. The aqueous layer was 10 further extracted three times with methyl isobutyl ketone, and the methyl isobutyl ketone layers obtained were combined with the previously obtained organic layer to obtain a solution containing 2-chloro-5 (aminomethyl)thiazole. The yield of 2-chloro-5 15 (aminomethyl)thiazole was 80.1%, and the yield of bis{ (2 chlorothiazol-5-yl)methyl}amine was 8.9%. Example 7 To a glass autoclave, 16.7 parts of 2-chloro-5 (chloromethyl)thiazole (content: 95.7%), 23.2 parts of 20 formalin (content: 37%) and 30.9 parts of a 21% ammonia solution in methanol were charged, and the mixture was reacted with stirring at an inner temperature of 700C for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.05 MPa. The reaction mixture containing 25 1,3,5-tris{(2-chlorothiazol-5-yl)methyl}-1,3,5- WO 2005/123704 PCT/JP2005/011095 23 hexahydrotriazine obtained was transferred into a four-neck flask by washing the autoclave with 60 parts of methanol, and then concentrated under reduced pressure to obtain 50.9 parts of a concentrated residue. To the concentrated 5 residue were added 73.2 parts of methanol and 32.8 parts of 35% hydrochloric acid, and the mixture was refluxed at an inner temperature of 60'C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 40'C, and then concentrated under reduced pressure to obtain 52.5 10 parts of a concentrated residue. To the concentrated residue were added 49 parts of methyl isobutyl ketone and 67.3 parts of an aqueous 27% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture to extraction treatment, and obtaining an organic layer and an 15 aqueous layer. The aqueous layer was further extracted three times with methyl isobutyl ketone, and the methyl isobutyl ketone layers obtained were combined with the previously obtained organic layer to obtain a solution containing 2-chloro-5-(aminomethyl)thiazole. The yield of 20 2-chloro-5-(aminomethyl)thiazole was 87.5%, and the yield of bis{ (2-chlorothiazol-5-yl)methyl}amine was 2.2%. Example 8 To a glass autoclave, 29.3 parts of 2-chloro-5 (chloromethyl)thiazole (content: 95.7%), 15.8 parts of 25 paraformaldehyde (content: 95% by weight) and 87.3 parts of WO 2005/123704 PCT/JP2005/011095 24 a 13% ammonia solution in methanol were charged, and the mixture was reacted with stirring at an inner temperature of 70*C for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.08 MPa. After 5 completion of the reaction, the reaction mixture containing 1,3,5-tris{(2-chlorothiazol-5-yl)methyl}-1,3,5 hexahydrotriazine was cooled to an inner temperature of 5 0 C to precipitate a solid, and the solid was collected by filtration. The collected solid was dried under reduced 10 pressure to obtain 21.9 parts of 1,3,5-tris{(2 chlorothiazol-5-yl)methyl}-1,3,5-hexahydrotriazine. MS(FD): m/z 480 at monoisotopic peak (isotopic pattern of Cl x 3) H-NMR (CDCl 3 , 270 MHz, 5/ppm) 15 3.50(brs, 2H), 3.82(s, 2H), 7.33(s, 1H)
'
3 C-NMR (CDCl 3 , 68 MHz, 5/ppm) 48.85, 72.34, 138.73, 139.29, 151.71 The 1,3,5-tris{ (2-chlorothiazol-5-yl)methyl}-1,3,5 hexahydrotriazine thus obtained was hydrolyzed with 20 hydrochloric acid in methanol to obtain 2-chloro-5 (amincmethyl)thiazole. Yield: 65.9%. The yield of bis{(2 chlorothiazol-5-yl)methyl}amine was 0.5%. Example 9 To a stainless-steel autoclave, 15.5 parts of 2 25 chloro-5-(chloromethyl)thiazole (content: 96.5%), 8.7 parts WO 2005/123704 PCT/JP2005/011095 25 of paraformaldehyde (content: 92%) and 24.4 parts of a 24% ammonia solution in methanol were charged, and the mixture was reacted with stirring at an inner temperature of 70'C for 3 hours. The maximum inner pressure (gauge pressure) 5 during the reaction was 0.02 MPa. The reaction mixture containing 1,3,5-tris{(2-chlorothiazol-5-yl)methyl}-1,3,5 hexahydrotriazine obtained was transferred into another flask by washing the autoclave with about 15 parts of methanol, and then concentrated under reduced pressure to 10 obtain 45.2 parts by weight of a concentrated residue. To the concentrated residue was added methanol so as to make up the solution volume to 228 parts, and then added 32.5 parts of 35% hydrochloric acid, and the mixture was maintained with stirring at an inner temperature of 500C 15 for 30 minutes. Then, the mixture was cooled to room temperature, and water was added thereto to obtain 260.2 parts of an aqueous solution containing 2-chloro-5 (aminomethyl)thiazole. The yield of 2-chloro-5 (aminomethyl)thiazole was 93.3%, and the yield of bis{ (2 20 chlorothiazol-5-yl)methyl}amine was 2.0%. Comparative Example 1 To a stainless-steel autoclave, 15.7 parts of 2 chloro-5-(chloromethyl)thiazole (content: 95.7%) and 25.4 parts of a 24% ammonia solution in methanol were charged, 25 and the mixture was reacted with stirring at an inner WO 2005/123704 PCT/JP2005/011095 26 temperature of 70*C for 3 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.28 MPa. The reaction mixture obtained was transferred into another flask by washing the autoclave with about 15 parts of 5 methanol, and then concentrated under reduced pressure to obtain 26.1 parts of a concentrated residue. To the concentrated residue was added methanol to obtain 228 parts of a solution containing 2-chloro-5-(aminomethyl)thiazole. The yield of 2-chloro-5-(aminomethyl)thiazole was 41.4%, 10 and the yield of bis{ (2-chlorothiazol-5-yl)methyl}amine was 24.5%. Example 10 To a glass autoclave, 29.3 parts of 2-chloro-5 (chloromethyl)thiazole (content: 95.7%), 15.8 parts of 15 paraformaldehyde (content: 95%), 56.9 parts of a 20% ammonia solution in methanol and 43.9 parts of toluene were charged, and the mixture was reacted with stirring at an inner temperature of 700C for 5 hours. The maximum inner pressure (gauge pressure) during the reaction was 0.09 MPa. 20 The reaction mixture containing 1,3,5-tris{(2 chlorothiazol-5-yl)methyl}-1,3,5-hexahydrotriazine obtained was transferred into a four-neck flask by washing the autoclave with 46 parts of methanol, and then concentrated under reduced pressure to obtain 162.4 parts of a 25 concentrated residue. To the concentrated residue was WO 2005/123704 PCT/JP2005/011095 27 added 23.6 parts of methanol and 57.4 parts of 35% hydrochloric acid, and the mixture was refluxed at an inner temperature of 600C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 40 0 C, and then 5 concentrated under reduced pressure to obtain 74.3 parts of a concentrated residue. To the concentrated residue were added 20 parts of water, 85.7 parts of methyl isobutyl ketone and 108.2 parts of an aqueous 27% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture 10 to extraction treatment, and obtaining organic layer and an aqueous layer. The aqueous layer was further extracted three times with toluene, and the toluene layers obtained were combined with the previously obtained organic layer to obtain a solution containing 2-chloro-5 15 (aminomethyl)thiazole. The yield of 2-chloro-5 (aminomethyl)thiazole was 92.3%, and the yield of bis{ (2 chlorothiazol-5-yl)methyl}amine was 2.2%. Since the aqueous layer after extracted with toluene contained 2.5% of 2-chloro-5-(aminomethyl)thiazole as 20 calculated from the yield, the reaction yield of 2-chloro 5-(aminomethyl)thiazole was 94.8%. Example 11 To a glass autoclave, 15.8 parts of paraformaldehyde (content: 95%) and 94.6 parts of a 12% ammonia solution in 25 methanol were charged. To the mixture was added 29 parts WO 2005/123704 PCT/JP2005/011095 28 of 2-chloro-5-(chloromethyl)thiazole (content: 96.6%) at room temperature, and the resultant mixture was reacted with stirring at an inner temperature of 40'C for 3 hours, then at an inner temperature of 50*C for 3 hours, and 5 further at an inner temperature of 70'C for 1 hour. The maximum inner pressure (gauge pressure) during the reaction was 0.09 MPa. The reaction mixture containing 1,3,5 tris{ (2-chlorothiazol-5-yl)methyl}-1,3,5-hexahydrotriazine obtained was transferred into a four-neck flask by washing 10 the autoclave with 60 parts of methanol, and then concentrated under reduced pressure to obtain 87.9 parts of a concentrated residue. To the concentrated residue was added 101 parts of water, and then the mixture was concentrated under reduced pressure to obtain 146.9 parts 15 of a concentrated residue. To the concentrated residue was added 117 parts of toluene to subject the mixture to extraction treatment at an inner temperature of 75'C to obtain 149 parts of a toluene layer and an aqueous layer. When the toluene layer was analyzed by HPLC, 1,3,5-tris{(2 20 chlorothiazol-5-yl)methyl}-1,3,5-hexahydrotriazine, 2 chloro-5-(aminomethyl)thiazole and bis{ (2-chlorothiazol-5 yl)methyl}amine were contained in yields of 91.8%, 2.7% and 2.1%, respectively. To 148.6 parts of the obtained toluene layer was added 25 21.5 parts of 35% hydrochloric acid with stirring, and then WO 2005/123704 PCT/JP2005/011095 29 allowed to stand to separate into an oil layer and an aqueous layer. To the oil layer was added 1.2 parts of water to subject the mixture to extraction treatment, and the aqueous layer obtained was combined with the previously 5 obtained aqueous layer. To the combined aqueous layer was added 39.5 parts of methanol, and the mixture was refluxed at an inner temperature of about 60*C for 1.5 hours. The mixture was cooled to an inner temperature of not higher than 40 0 C, and then concentrated under reduced pressure to 10 obtain 38.9 parts of a concentrated residue. To the concentrated residue were added 20 parts of water, 82.6 parts of toluene and 35 parts of an aqueous 27% sodium hydroxide solution to adjust to pH 13, thereby subjecting the mixture to extraction treatment, and obtaining an 15 organic layer and an aqueous layer. The aqueous layer was further extracted three times with toluene, and the toluene layers obtained were combined with the previously obtained organic layer to obtain a solution containing 2-chloro-5 (aminomethyl)thiazole. The yield of 2-chloro-5 20 (aminomethyl)thiazole was 87.2%, and the yield of bis{ (2 chlorothiazol-5-yl)methyllamine was 1.9%. Industrial Applicability According to the present invention, the thiazole 25 compound of formula (3) which is useful as an intermediate WO 2005/123704 PCT/JP2005/011095 30 for pharmaceuticals and agrochemicals can be prepared industrially advantageously with suppressing the formation of the by-product of formula (4).

Claims (13)

1. A process for preparing a thiazole compound of formula (3): NH 2 (3) 5 wherein X 1 represents a hydrogen atom or a halogen atom, which comprises the steps of: reacting a compound of formula (1): x S2 wherein X1 is as defined above, and X2 represents halogen 10 atom, with ammonia and formaldehyde to obtain a hexahydrotriazine compound of formula (2): xi N s N
(2) N wherein X 1 is as defined above, and hydrolyzing the resulting hexahydrotriazine compound of formula (2). 15 2. The process according to claim 1, wherein formaldehyde is paraformaldehyde or formalin.
3. The process according to claim 1, wherein formaldehyde is used in the amount of 1 to 10 moles per mol WO 2005/123704 PCT/JP2005/011095 32 of the compound of formula (1).
4. The process according to claim 1, wherein ammonia is used in the amount of 2 to 10 moles per mol of the compound of formula (1).
5 5. The process according to claim 1, wherein the hydrolysis is carried out by allowing to come into contact the hexahydrotriazine compound of formula (2) *and an aqueous solution of an acid.
6. The process according to claim 5, wherein the 10 hydrolysis is carried out in the presence of a lower alcohol compound.
7. A hexahydrotriazine compound of formula (2): xi S ""N N S N X wherein X 1 represents a hydrogen atom or a halogen atom, or 15 an acid addition salt thereof.
8. A process for preparing a hexahydrotriazine compound of formula (2): WO 2005/123704 PCT/JP2005/011095 33 xi S N s N N (2) N x wherein X1 represents a hydrogen atom or a halogen atom, which comprises reacting a compound of formula (1): 5 wherein X is as defined above, and X2 represents a halogen atom, with ammonia and formaldehyde.
9. The process according to claim 8, wherein formaldehyde is used in the amount of 1 to 10 moles per mol of the compound of formula (1).
10 10. The process according to claim 8, wherein ammonia is used in the amount .of 2 to 10 moles per mol of the compound of formula (1).
11. A process for preparing a thiazole compound of formula (3): 15 NH 2 (3) wherein X 1 represents a halogen atom, or a hydrogen atom, which comprises hydrolyzing a hexahydrotriazine compound of formula (2): WO 2005/123704 PCT/JP2005/011095 34 xi S N N-1 xx N X1 wherein X' is as defined above.
12. The process according to claim 11, wherein the hydrolysis is carried out by bringing the hexahydrotriazine 5 compound of formula (2) into contact with an aqueous solution of an acid.
13. The process for according to claim 12, wherein the hydrolysis is carried out in the presence of a lower alcohol compound.
AU2005254863A 2004-06-17 2005-06-10 Compound for preparing thiazole by aminomethylation Ceased AU2005254863B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2004179472 2004-06-17
JP2004-179472 2004-06-17
JP2005110701 2005-04-07
JP2005-110701 2005-04-07
PCT/JP2005/011095 WO2005123704A1 (en) 2004-06-17 2005-06-10 Compound for preparing thiazole by aminomethylation

Publications (2)

Publication Number Publication Date
AU2005254863A1 true AU2005254863A1 (en) 2005-12-29
AU2005254863B2 AU2005254863B2 (en) 2010-12-23

Family

ID=34970323

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005254863A Ceased AU2005254863B2 (en) 2004-06-17 2005-06-10 Compound for preparing thiazole by aminomethylation

Country Status (14)

Country Link
US (1) US7439357B2 (en)
EP (1) EP1756075B1 (en)
JP (1) JP4788201B2 (en)
KR (1) KR101214414B1 (en)
CN (1) CN1968938B (en)
AR (1) AR049695A1 (en)
AU (1) AU2005254863B2 (en)
BR (1) BRPI0512168B1 (en)
DK (1) DK1756075T3 (en)
ES (1) ES2425477T3 (en)
IL (1) IL179701A (en)
RU (1) RU2372340C2 (en)
TW (1) TWI344958B (en)
WO (1) WO2005123704A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4839660B2 (en) * 2005-04-07 2011-12-21 住友化学株式会社 Method for producing thiazole compound
BRPI0619965A2 (en) * 2005-12-15 2011-10-25 Sumitomo Chemical Co method to selectively produce primary amine compound
JP5130706B2 (en) * 2005-12-15 2013-01-30 住友化学株式会社 Method for producing selective primary amine compound
JP4848762B2 (en) * 2005-12-26 2011-12-28 住友化学株式会社 Method for producing primary amine compound
WO2008136093A1 (en) * 2007-04-24 2008-11-13 Nippon Soda Co., Ltd. Process for producing substituted methylamine compound and triazine derivative
JP6217646B2 (en) * 2012-11-02 2017-10-25 住友化学株式会社 Method for producing compound
WO2018015344A1 (en) * 2016-07-18 2018-01-25 Sika Technology Ag Catalyst for curable compositions containing hexahydrotriazine structural units

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU798102A1 (en) 1977-08-25 1981-01-23 Предприятие П/Я В-2287 Method of combined preparation of n,n,n-tribenzylhexahydrotriazine-1,3,5 and n-methylbenzylamino-n'-benzyliminomethylene
ATE166051T1 (en) 1987-08-01 1998-05-15 Takeda Chemical Industries Ltd INTERMEDIATE PRODUCTS, THEIR PRODUCTION AND USE FOR THE PRODUCTION OF ALPHA UNSATURATED AMINE
US5180833A (en) 1990-03-16 1993-01-19 Takeda Chemical Industries, Ltd. Process for the preparation of chlorothiazole derivatives
JPH0421674A (en) 1990-05-15 1992-01-24 Nippon Soda Co Ltd Production of 2-chloro-5-(aminomethyl)thiazole
JPH05286936A (en) 1992-04-06 1993-11-02 Takeda Chem Ind Ltd Production of formamide derivative and new formamide derivative
TW541294B (en) 1998-10-12 2003-07-11 Ihara Chemical Ind Co Process for producing aminomethyl-heterocyclic derivative
JP4276720B2 (en) 1998-11-05 2009-06-10 住友化学株式会社 Process for producing 5-aminomethyl-2-chlorothiazole or a salt thereof
DE10061083A1 (en) 2000-12-08 2002-06-13 Bayer Ag Bis (2-chloro-thiazolyl-5-methyl) amine and its salts and process for working up 5-aminomethyl-2-chloro-thiazole and bis (2-chloro-thiazole-5-methyl) amine containing reaction mixtures
JP4839660B2 (en) * 2005-04-07 2011-12-21 住友化学株式会社 Method for producing thiazole compound

Also Published As

Publication number Publication date
US20070197803A1 (en) 2007-08-23
IL179701A0 (en) 2007-05-15
CN1968938A (en) 2007-05-23
JP2006312617A (en) 2006-11-16
BRPI0512168B1 (en) 2013-12-31
AU2005254863B2 (en) 2010-12-23
ES2425477T3 (en) 2013-10-15
EP1756075B1 (en) 2013-08-07
JP4788201B2 (en) 2011-10-05
TW200602331A (en) 2006-01-16
TWI344958B (en) 2011-07-11
KR20070026597A (en) 2007-03-08
KR101214414B1 (en) 2012-12-21
DK1756075T3 (en) 2013-08-26
US7439357B2 (en) 2008-10-21
BRPI0512168A (en) 2008-02-12
CN1968938B (en) 2010-05-05
WO2005123704A1 (en) 2005-12-29
RU2372340C2 (en) 2009-11-10
EP1756075A1 (en) 2007-02-28
RU2007101508A (en) 2008-07-27
IL179701A (en) 2012-03-29
AR049695A1 (en) 2006-08-30

Similar Documents

Publication Publication Date Title
AU2005254863B2 (en) Compound for preparing thiazole by aminomethylation
KR101385395B1 (en) Method for selectively producing primary amine compound
EP1866297B1 (en) Process for producing an aminomethyl thiazole compound
KR101565391B1 (en) Method for producing 2,2-difluoroethylamine derivatives by amide hydrogenation
US7439408B2 (en) Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles
US6861522B2 (en) Process for the manufacture of thiazole derivatives with pesticidal activity
JP6217646B2 (en) Method for producing compound
ZA200610352B (en) Compound for preparing thiazole by aminomethylation
JP5130706B2 (en) Method for producing selective primary amine compound
US8754235B2 (en) Method for producing 5-(aminomethyl)-2-chlorothiazole

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired